NEW YORK – Mobile healthcare startup Essenlix announced on Thursday that it is partnering with Roche Diagnostics Norway on an initiative to increase at-home testing.
Roche will use Essenlix's iMost device as the platform for its at-home test solution in Norway, Essenlix said in a statement.
The device is cellphone-based and allows users to perform diagnostic tests using a single drop of body fluid, returning results within one minute and sending those results immediately to medical professionals. The device can perform tests using a variety of sample types, including blood, saliva, urine, swabs, sputum, breath, mucus, and tissues. It can also perform a variety of types of tests, including immunoassays, colorimetric assays, cytology and pathology, and nucleic acid assays, the company said.
The device makes use of a patient's cellphone and includes an adaptor and a sample holder. It uses nanotechnology, advance imagining, and nano-abled artificial intelligence and machine learning, Essenlix said. It was derived from new principles in "sample and biochemistry preparation, measurement methodology, and instrumentation," the company added.
The firm has built manufacturing lines with a capacity of more than 10 million iMost test cards annually.